Correlation Between Dermata Therapeutics and Cingulate
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and Cingulate at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and Cingulate into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics Warrant and Cingulate, you can compare the effects of market volatilities on Dermata Therapeutics and Cingulate and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of Cingulate. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and Cingulate.
Diversification Opportunities for Dermata Therapeutics and Cingulate
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Dermata and Cingulate is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics Warrant and Cingulate in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cingulate and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics Warrant are associated (or correlated) with Cingulate. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cingulate has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and Cingulate go up and down completely randomly.
Pair Corralation between Dermata Therapeutics and Cingulate
Assuming the 90 days horizon Dermata Therapeutics Warrant is expected to generate 7.45 times more return on investment than Cingulate. However, Dermata Therapeutics is 7.45 times more volatile than Cingulate. It trades about 0.15 of its potential returns per unit of risk. Cingulate is currently generating about 0.01 per unit of risk. If you would invest 6.35 in Dermata Therapeutics Warrant on November 2, 2024 and sell it today you would lose (3.38) from holding Dermata Therapeutics Warrant or give up 53.23% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 56.48% |
| Values | Daily Returns |
Dermata Therapeutics Warrant vs. Cingulate
Performance |
| Timeline |
| Dermata Therapeutics |
| Cingulate |
Dermata Therapeutics and Cingulate Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dermata Therapeutics and Cingulate
The main advantage of trading using opposite Dermata Therapeutics and Cingulate positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, Cingulate can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cingulate will offset losses from the drop in Cingulate's long position.The idea behind Dermata Therapeutics Warrant and Cingulate pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Cingulate vs. SAB Biotherapeutics | Cingulate vs. Senti Biosciences | Cingulate vs. Aerovate Therapeutics | Cingulate vs. Adagene |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |